Juvenile diabetes and visual impairment: Wolfram syndrome

QJM. 2019 Oct 1;112(10):803-804. doi: 10.1093/qjmed/hcz066.

Authors

A K Annamalai¹, S Ellard², M Shanmugam³, T P Jai Juganya⁴, E De Franco²

Affiliations

¹ Department of Endocrinology, Ashwin Speciality Hospital, Madurai, India.
² Department of Molecular Genetics, University of Exeter Medical School, UK.
³ Department of Neuro-Ophthalmology, Aravind Eye Care Hospitals, Madurai, India.
⁴ Department of Medicine, Meenakshi Mission Hospital and Research Centre, Madurai, India.

No abstract available

Publication types

Case Reports

MeSH terms

Biphasic Insulins / therapeutic use
Child
Diabetes Mellitus, Type 1 / drug therapy
Diabetes Mellitus, Type 1 / genetics*
Frameshift Mutation / genetics
Homozygote
Humans
Hypoglycemic Agents / therapeutic use
Male
Membrane Proteins / genetics
Treatment Outcome
Vision, Low / drug therapy
Vision, Low / genetics*
Wolfram Syndrome / drug therapy
Wolfram Syndrome / genetics*

Substances

Biphasic Insulins
Hypoglycemic Agents
Membrane Proteins
wolframin protein